Elastase is a globular glycoprotein and belongs to the chymotrypsin family. It is involved in several inflammatory cascades on the basis of cleaving the important connective tissue protein elastin, and is strictly regulated to a balance by several endogenous inhibitors. When elastase and its inhibitors are out of balance, severe diseases will develop, especially those involved in the cardiopulmonary system. Much attention has been attracted in seeking innovative elastase inhibitors and various advancements have been taken on clinical trials of these inhibitors. Natural functional peptides from venomous animals have been shown to have anti-protease properties. Here, we identified a kazal-type serine protease inhibitor named ShSPI from the cDNA library of the venom glands of Scolopendra hainanum. ShSPI showed significant inhibitory effects on porcine pancreatic elastase and human neutrophils elastase with Ki values of 225.83 ± 20 nM and 12.61 ± 2 nM, respectively. Together, our results suggest that ShSPI may be an excellent candidate to develop a drug for cardiopulmonary diseases.
Introduction
Centipedes are predatory arthropods distributed on every continent except Antarctica. They prey mainly by secreting venom from the venom glands, which are connected to the first pair forcipules. Centipede venoms are comprised of proteins and peptides, which show a variety of biological
Results

Determination of the Primary Structure of ShSPI
A cDNA sequence encoding a precursor protein composed of 61 amino acid (aa) was found. A hypothetical signal peptide (22 aa), pro-peptide (-QRNRR-), and a mature peptide (34 aa) were identified ( Figure 1A , marked by box) through online analysis (SignalP-5.0, http://www.cbs.dtu.dk/ services/SignalP/). BLAST search indicated that the mature peptide named ShSPI ( Figure 1A , marked by grey color) shares pair sequence similarity with other atypical kazal family ( Figure 1C ). The amino acid sequence of ShSPI is indicated in Figure 1B : CPQVCPAIYQPVFDEFGRMYSNSCEMQRARCLRG.
Refolding of ShSPI
We chemically synthesized linear ShSPI and refolded its two disulfide bridges with the glutathione redox system (Figure 2A ). C 18 reverse phase-high performance liquid chromatography (RP-HPLC) was conducted to purify the refolded ShSPI, with the elution of indicated gradients of acetonitrile (containing 0.1% (v/v) trifluoroacetic acid) at a flow rate of 1.5 mL/min. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) was applied to determine the purity of peptides to be higher than 95% ( Figure 2B ). Consistent with the predicted molecular weight (MW) of ShSPI, the observed MW of refolded ShSPI was 3952.7 Da, indicating that the two disulfide bridges have been refolded successfully. The primary structure of ShSPI. The disulfide bond pairing mode is C1-C4/C2-C3. ShSPI consists of a cystine-stabilized α-helical (CSH) motif formed by residues Ser-23 to Arg-33, and a two-stranded antiparallel β-sheet (strand 1, Pro-11 to Asp-14; and strand 2, Gly-17 to . The putative P1-P1' sites were suggested using HNE as reference enzyme and the nomenclature of Schechter and Berger [18, 19] . (C) Similarity of ShSPI to selected atypical kazal family and classical kazal family. The percent identity (Per.Ident) (%) of ShSPI with each sequence has been shown to demonstrate their sequence similarity. The cysteine residues in domains are shown in grey color. The conserved residues are marked with #, and residues with high similarity are indicated by asterisk. Figure 2 . Refolding of ShSPI. (A) Linear ShSPI was synthesized and refolding analysis was performed by C18 HPLC. (B) MALDI-TOF MS was used to confirm the purity of ShSPI to be higher than 95%. Average molecular weight of refolding ShSPI and linear ShSPI are 3952.8 and 3956.7 Da, respectively, which indicated that two disulfide bonds were formed successfully.
ShSPI Inhibits Elastase Potently and Selectively
Based on the sequence alignment analysis, we speculate that ShSPI may contain inhibitory activity on some proteases. The enzyme activity of ShSPI to a diversity of proteases was assayed. ShSPI (500 nM) exhibited significant inhibitory activity on porcine pancreatic elastase (PPE) and human neutrophil elastase (HNE), while it showed no inhibitory activity against factor Xa (FXa), factor XIIa (FXIIa), kallikrein, thrombin, trypsin, chymotrypsin, or cathepsin G (CG) ( Figure 3A ).
Sivelestat (also known as ONO-5046), which is a potent elastase inhibitor, has been used as a clinical drug [20] . It has been reported that sivelestat has little inhibitory activity to PPE and strong The primary structure of ShSPI. The disulfide bond pairing mode is C 1 -C 4 /C 2 -C 3 . ShSPI consists of a cystine-stabilized α-helical (CSH) motif formed by residues Ser-23 to Arg-33, and a two-stranded antiparallel β-sheet (strand 1, Pro-11 to Asp-14; and strand 2, Gly-17 to Tyr-20). The putative P1-P1 sites were suggested using HNE as reference enzyme and the nomenclature of Schechter and Berger [18, 19] . (C) Similarity of ShSPI to selected atypical kazal family and classical kazal family. The percent identity (Per.Ident) (%) of ShSPI with each sequence has been shown to demonstrate their sequence similarity. The cysteine residues in domains are shown in grey color. The conserved residues are marked with #, and residues with high similarity are indicated by asterisk. [18, 19] . (C) Similarity of ShSPI to selected atypical kazal family and classical kazal family. The percent identity (Per.Ident) (%) of ShSPI with each sequence has been shown to demonstrate their sequence similarity. The cysteine residues in domains are shown in grey color. The conserved residues are marked with #, and residues with high similarity are indicated by asterisk. 
Sivelestat (also known as ONO-5046), which is a potent elastase inhibitor, has been used as a clinical drug [20] . It has been reported that sivelestat has little inhibitory activity to PPE and strong HPLC. (B) MALDI-TOF MS was used to confirm the purity of ShSPI to be higher than 95%. Average molecular weight of refolding ShSPI and linear ShSPI are 3952.8 and 3956.7 Da, respectively, which indicated that two disulfide bonds were formed successfully.
to PPE and HNE of ShSPI and sivelestat. As illustrated in Figure 3B ,C, both ShSPI and sivelestat significantly inhibited the activity of PPE and HNE in a dose-dependent manner. However, ShSPI showed better inhibitory effect on PPE and HNE than sivelestat. At the concentration of 500 nM, the inhibitory rate of ShSPI and sivelestat on PPE was about 18% and 65%, respectively. At the concentration of 50 nM, ShSPI and sivelestat exhibited an effect on HNE with an inhibitory rate of 16% and 44%, respectively. 
Enzymatic Kinetics of ShSPI on Elastase
The enzymatic kinetics of ShSPI on elastase was further explored; varying doses of ShSPI (from 0 to 885 nM) and elastase colorimetric substrate (30, 60, and 90 μg/mL) were used. The Dixon plot analysis showed that linear curves converged on the x-axis, suggesting that ShSPI is a noncompetitive inhibitor of elastase ( Figure 4A ,B) and the Ki values to PPE and HNE were 225.8 ± 20 nM and 12.6 ± 2 nM, respectively ( Table 1 ). Sivelestat (also known as ONO-5046), which is a potent elastase inhibitor, has been used as a clinical drug [20] . It has been reported that sivelestat has little inhibitory activity to PPE and strong inhibitory activity to HNE with a Ki value of 200 ± 20 nM [21] . We compared the inhibitory activity to PPE and HNE of ShSPI and sivelestat. As illustrated in Figure 3B ,C, both ShSPI and sivelestat significantly inhibited the activity of PPE and HNE in a dose-dependent manner. However, ShSPI showed better inhibitory effect on PPE and HNE than sivelestat. At the concentration of 500 nM, the inhibitory rate of ShSPI and sivelestat on PPE was about 18% and 65%, respectively. At the concentration of 50 nM, ShSPI and sivelestat exhibited an effect on HNE with an inhibitory rate of 16% and 44%, respectively.
The enzymatic kinetics of ShSPI on elastase was further explored; varying doses of ShSPI (from 0 to 885 nM) and elastase colorimetric substrate (30, 60 , and 90 µg/mL) were used. The Dixon plot analysis showed that linear curves converged on the x-axis, suggesting that ShSPI is a non-competitive inhibitor of elastase ( Figure 4A ,B) and the Ki values to PPE and HNE were 225.8 ± 20 nM and 12.6 ± 2 nM, respectively (Table 1) . inhibitory activity to HNE with a Ki value of 200 ± 20 nM [21] . We compared the inhibitory activity to PPE and HNE of ShSPI and sivelestat. As illustrated in Figure 3B ,C, both ShSPI and sivelestat significantly inhibited the activity of PPE and HNE in a dose-dependent manner. However, ShSPI showed better inhibitory effect on PPE and HNE than sivelestat. At the concentration of 500 nM, the inhibitory rate of ShSPI and sivelestat on PPE was about 18% and 65%, respectively. At the concentration of 50 nM, ShSPI and sivelestat exhibited an effect on HNE with an inhibitory rate of 16% and 44%, respectively. 
The enzymatic kinetics of ShSPI on elastase was further explored; varying doses of ShSPI (from 0 to 885 nM) and elastase colorimetric substrate (30, 60 , and 90 μg/mL) were used. The Dixon plot analysis showed that linear curves converged on the x-axis, suggesting that ShSPI is a noncompetitive inhibitor of elastase ( Figure 4A ,B) and the Ki values to PPE and HNE were 225.8 ± 20 nM and 12.6 ± 2 nM, respectively (Table 1 ). 
Binding Kinetics of ShSPI on Elastase
To verify the direct interaction of ShSPI and elastase, surface plasmon resonance (SPR) biosensor technology was used to determine the binding affinity of ShSPI to HNE and PPE. The ability of ShSPI binding to elastase was reflected by the response values (RU) that were directly recorded by the Biacore 3000 instrument (GE Healthcare Life Sciences, Pittsburgh, PA, USA). As shown in Figure 4C ,D, the RU increased with increasing elastase (HNE or PPE) concentration, which indicated that ShSPI binds to elastase in a concentration dependent manner.
The equilibrium dissociation constant (K D , M) of ShSPI to PPE was 1.0 × 10 −7 and to HNE was 4.2 × 10 −8 (as listed in Table 1 ). The binding of ShSPI with HNE was stronger than that with PPE, which is consistent with the protease inhibition assays.
The NMR Structure of ShSPI
The three-dimensional structure of the ShSPI peptide was determined using two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopy. The chemical shift analysis was used to identify the disulfide-bonded or free-state cystein, and cis-or trans-conformation of the proline. [22] , while the Cγ values for prolines with cis-conformation fall at 24.4 ± 0.7 ppm. The unambiguous and strong H(i)-Hδ(i+1: Pro)(dαδ) nuclear overhauser effect (NOE) signals in the NOESY spectra also confirmed the trans-conformation. The H(i)-Hδ(i+1: Pro)(dαδ) or Hα(i)-Hα(i+1: Pro)(dαα) NOEs of Pro (i+1) and its immediate preceding residue (i) were used to assign the configuration of Pro residues. The strong dαδ NOEs indicates the trans-configuration while strong dαα NOEs indicates the cis-configuration. The structural statistics for the final 15 structure ensembles ( Figure 5A ,B) are given in Table 2 . The structure of ShSPI consists of a cystine-stabilized α-helical (CSH) motif formed by residues Ser-23 to Arg-33, and a two-stranded antiparallel β-sheet (strand 1, Pro-11 to Asp-14; and strand 2, Gly-17 to . The N-terminal loop is stabilized by the formation of disulfide bonds. The NOE pattern demonstrates that Cys-1 (C 1 ) forms a disulfide bond with Cys-31 (C 4 ), while Cys-5 (C 2 ) with Cys-24 (C 3 ). This is further evidenced by the partial reduction and MS data (data not shown). Taken together, ShSPI contains the C 1 -C 4 and C 2 -C 3 disulfide bond connectivity ( Figure 1B) .
ShSPI is an Atypical Kazal Domain and the Minimal Functional Unit
As the serine protease inhibitors, the canonical kazal domain is composed of one α-helix and three-stranded anti-parallel β-sheet, six cysteins forming three disulfide bonds with the pattern of C 1 -C 5 , C 2 -C 4 , and C 3 -C 6 . Kazal domains with two disulfide bonds and the absence of the third and six cysteines were referred as atypical kazal domains [23] . The ShSPI belongs to this class. The structure superimposition with the canonical kazal domain OMSVP3 (pdb: 1IY5) is demonstrated in Figure 5C , which shows that the tertiary structure of ShSPI resembles the core structure of canonical kazal domain.
To gain insights into the difference between ShSPI and other atypical kazal inhibitors, we superimposed the three-dimensional structures of ShSPI with other reported atypical kazal domain structures, including anemonia elastase inhibitor (AEI, pdb: 1Y1B) ( Figure 5D ), domain 6 of LEKT1 (pdb: 1H0Z) ( Figure 5E ), and Greglin (pdb: 4GI3) ( Figure 5F ). Compared with ShSPI, other atypical kazal domains show either NH 2 -or COOH-terminal long or short extensions. The structural comparison demonstrates that the ShSPI motif with 34 residues is the core structure contained by all of the atypical kazal domains. Meanwhile, ShSPI contains very short sequence with only three residues between the first two cysteines, instead of 6-13 residues in the typical kazal domains ( Figure 1C, bottom) . Together with its activity, to the best of our knowledge, the ShSPI could be regarded as the minimal functional unit.
Point Mutations Confirm the Important Residues of ShSPI
The sequence analysis of the kazal-family shows that P3, the second conserved cysteine residue, and P15 with the residue asparagine are highly conserved, while the remaining ten contact residues are hypervariable. The numbering is according to the nomenclature of Schechter and Berger and using HNE as reference enzyme [18, 19] . We supposed that ShSPI conforms to this regular pattern. The ShSPI mutant C5A (P3) and N22A (P15 ) of ShSPI are not soluble or show no activity (Ki > 1 mM) ( Table 3) , indicating that the point mutation disrupts the global fold and the mutant could not fold properly (data not shown). These results confirm the essential importance of residues in the P3 and P15 positions. The numbering is according to the nomenclature of Schechter and Berger and using HNE as reference enzyme [18, 19] . Important positions are indicated in Figure 1B .
To further confirm the important residues for the interaction between ShSPI and HNE, point mutation method was applied. Through the structural analysis, several ShSPI mutants were synthesized, including P2A, Q3A, V4A, P6A Y9A, Q10A, S21A, N22A, and E25A. The inhibitory effects of these mutants to HNE were tested. Mutants Y9A, N22A, and E25A did not show any inhibitory activity to HNE, demonstrating that these three residues are vital for the inhibitory activity of ShSPI. Other residues of ShSPI, such as Pro2, Gln3, and Pro6, are also important for the inhibitory to elastase. The single mutation significantly decreased their HNE activity. The Ki values of these mutants are listed in Table 3 .
ShSPI Showed Plasma Stability
The structural information shows that ShSPI is the minimal functional unit and the folding is stabilized through the two intra-disulfide bonds and the tertiary structure. To investigate the stability of ShSPI in physiological condition, ShSPI was co-incubated with human plasma over 48 h. ShSPI was found to be remarkably stable in human plasma, with no significant degradation over 48 h. Compared with the basal inhibitory activity, the inhibitory percentage to HNE and PPE was still around 12% and 17%, respectively ( Figure 5G ). Stability of ShSPI in plasma could support the hypothesis that ShSPI could be stable and affect strongly in vivo.
Discussion
Venomous creatures are considered to be a very distinctive class of species among animals [22] . Venomous animals are equipped with venom glands and venoms, which provide them outstanding advantages for their existence [24] [25] [26] . Toxins from centipedes have been well studied. Some of them have been established as important tools for predation, and some of them are useful candidates for drug design [22, 27] . To the best of our knowledge, as a novel member of centipedes distributed only in Hainan and Guangxi province, China, the bioactive peptides from venom of S. hainanum have not been reported [26, 28] . For the first time, we identified a new serine protease inhibitor (SPI) from S. hainanum, named as ShSPI and characterized as an atypical kazal motif. Through the sequence and structural analysis, the ShSPI is considered as the minimal functional unit. The core motif includes the reactive loop with extended conformation and appropriate backbone geometry, the two disulfide bonds-stabilized α-helical (CSH) motif, and two-stranded anti-parallel β-sheet. It is missing two cysteine residues and the corresponding disulfide bond is not essential for inhibitor reactivity and stability [23] .
SPIs are widely distributed in a variety of species [29, 30] . They are able to inhibit the catalytic activity of proteolytic enzymes and guarantee the inhibiting proteolysis of proteinase, which are important in poisonous animals' biological processes for survival [31, 32] . Among kazal-type SPIs, most domains described so far contain six highly conserved cysteine residues, with the formation of three intra-domain disulfide bonds. In our study, ShSPI has only two disulfide bonds, thus belongs to atypical kazal family. However, the tertiary structure of ShSPI resembles the core structure of canonical kazal domain, which may provide the primary interaction site of ShSPI to proteinases. Classical SPIs with multiple kazal domains show broad-spectrum inhibition on serine proteinases such as trypsin, subtilisin, thrombin, chymotrypsin, and elastase potently. Despite the single kazal domain instead of multiple kazal domains in other SPIs, ShSPI has a stable structure which exhibits strong activity against elastase. In consistence with this, our results show that ShSPI specifically inhibits elastase with Ki values of 225.83 ± 20 nM to PPE and 12.61 ± 2 nM to HNE.
Other atypical kazal family inhibitors have shown narrower specificity compared to the classical kazal family. However, ShSPI is more specific. The structural similarity and difference within these inhibitors may give some explanation. All of the atypical kazal family inhibitors have the similar core structure, while ShSPI does not have the additional NH 2 -or COOH-terminal extensions and contains very short sequence with only three residues between the first two cysteines, instead of 6-13 residues in the typical kazal domains. It was reported that, when rigidity increases near the reactive site, the inhibitor is more likely to show narrower specificity. For example, compared with wild-type AEI, the AEI analog (just one aa between the first two cysteines) did not show inhibitory activity against PPE, while it retained almost the same potent inhibitory activity toward Streptomyces griseus protease B [33] . As a result, the characteristics of ShSPI can make it easier to reach the interaction site of elastase, and ShSPI could be a potential probe to study the interaction characteristics between SPIs and enzymes, which could provide us a clue to design the inhibitors with high specificity and selectivity.
Sivelestat, the selective neutrophil elastase inhibitor has been safely used in specific clinical scenarios, including refractory Kawasaki disease [34] and acute lung injury [16, 35] . It also has been found that sivelestat can improve the survival in the clinical relevant animal models of sepsis, in which not only did damage occur in the lung, but also other organs including kidneys, liver, and heart were impaired [36] [37] [38] [39] . From the results, we found that ShSPI exhibited better effects on the inhibitory of PPE and HNE than that of sivelestat at the same concentration. ShSPI might be an excellent candidate to develop the drug for the diseases sivelestat treated.
In conclusion, a potent elastase inhibitor, named ShSPI, was identified and characterized from the centipede S. hainanum for the first time. ShSPI has a stable three-dimensional structure and strongly binds to the catalytic site of elastase, which confirmed the inhibitory effect on elastase. Our findings have important implications for the design and development of new drugs for diseases related with the destruction of HNE.
Materials and Methods
RNA Extraction and cDNA Synthesis
The venom glands of S. hainanum were collected. Total RNA was isolated by using TRIzol reagent (15596018, Invitrogen, Waltham, MA, USA), and cDNA was reverse-transcribed using SuperScript II Reverse Transcriptase and oligo(dT)12−18 primer with the SMART™ PCR cDNA synthesis kit (Clontech, Palo Alto, CA, USA). The clones of cDNA (>350 bp) were selected and sequenced by Sangon Biotech (Shanghai, China).
Peptides Synthesis and Refolding
Linear ShSPI and its mutant peptides were synthesized by GL biochem (Shanghai, China). Single site mutation peptides were designed according to the method described [40] .
Peptides were refolded in a solution (pH 7.2) containing 10 mM glutathione (V900456, Sigma, Saint Loui, MO, USA) and 100 mM oxidized glutathione (V900363, Sigma, Saint Loui, MO, USA). The refolding solution was placed at 28 • C for 24 h. Then, we separated the different fractions using Reverse Phase-High Performance Liquid Chromatography (RP-HPLC) techniques and C 18 column (Waters, Milford, MA, USA, 5 µm particle size, 250 mm × 4.6 mm). Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS, Autoflex speed TOF/TOF, Bruker Daltonik GmbH, Bruker Corporation, Germany) was performed to determine the purity of the peptides, and refolded ShSPI with purity higher than 95% was collected for further research.
Assignment of the Disulfide Bonds
Refolded ShSPI (1 mg) was dissolved in 100 µL of 6 M guanidine hydrochloride (pH 6.0, G4505, Sigma, Saint Loui, MO, USA), and incubated for 30 min at 37 • C. Afterwards, 100 µL of 0.1 M TCEP (75259, Sigma, Saint Loui, MO, USA) were added to the sample and maintained for 3 min at 37 • C, and then 800 µL of 0.1% TFA-H 2 O were added immediately. Fractions were purified by using C 18 RP-HPLC (Waters Corporation, 34 Maple Street Milford, MA, USA) with a linear acetonitrile gradient (0-60% over 60 min). The intermediate peptides were gathered, lyophilized, and alkylated with 0.5 M iodoacetamide (pH 8.3, I1149, Sigma, Saint Loui, MO, USA) for 1 min at 25 • C. Alkylated peptides were isolated and desalted by C 18 RP-HPLC, and Edman degradation was performed on a Shimadzu protein sequencer (PPSQ-31A, Shimadzu, Nakagyo-ku, Kyoto 604-8511, Japan).
Protease Assays
Human neutrophils elastase (HNE, E8140), porcine pancreatic elastase (PPE, E0127), cathepsin G (CG, C4428), human trypsin (T6424), α-chymotrypsin from human pancreas (C8946), and thrombin The NOE were analyzed and assigned manually, and then converted into distance constraints. The program xplor-NIH [45] was used to calculate the structure. The quality of the NMR ensembles was evaluated by MolProbity [46] .
Plasma Stability
Lyophilized human plasma (400100, Cayman, Ann Arbor, MI, USA) was resuspended in sterile water according to the instruction, then ShSPI was added to each equivalent volume with a final concentration of 500 nM, and samples were co-incubated at 37 • C for two days. Triplicate samples were collected at selected time points (0, 6, 12, 18, 24, 30, 36, 42 , and 48 h) and protease activity was tested as described above.
Statistical Analysis
Experimental results were tested statistically by an unpaired two-tailed student's t-test and expressed as mean ± SEM by GraphPad Prism (Version 5.0, GraphPad Software, San Diego, CA, USA). Data were considered statistically significant when p < 0.05.
